Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

FHLC vs FTXH overlap: 51% of top holdings shared

Bottom line

How much do FHLC and FTXH overlap?

51% of their top holdings overlap by weight. 11 securities appear in both funds' top 25, making up 46.4% of FHLC's assets and 54.2% of FTXH's. They share a meaningful core but differ in the rest of the portfolio.

FHLC holds far more positions (337 vs 51), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

FHLCFTXH
Weight overlap (top 25)51%
Shared holdings11
Weight in shared holdings46.4%54.2%
Total positions33751
Expense ratio0.084%0.6%
Holdings as ofJul 31, 2026Jun 30, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Holdings FHLC and FTXH have in common

Holding% of FHLC% of FTXHOverlap
Eli Lilly & Co13.35%7.77%7.77%
Johnson & Johnson8.93%6.96%6.96%
AbbVie Inc6.42%7.39%6.42%
Merck & Co Inc4.66%7.07%4.66%
Amgen Inc3.00%3.18%3.00%
Gilead Sciences Inc2.34%2.89%2.34%
Pfizer Inc2.06%2.97%2.06%
Bristol-Myers Squibb Co1.93%6.29%1.93%
Vertex Pharmaceuticals Inc1.76%3.41%1.76%
Regeneron Pharmaceuticals Inc1.15%2.72%1.15%
Cardinal Health Inc0.78%3.53%0.78%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in FHLC

  1. UnitedHealth Group Inc — 5.44%
  2. Thermo Fisher Scientific Inc — 3.09%
  3. Abbott Laboratories — 2.66%
  4. CVS Health Corp — 1.92%
  5. Intuitive Surgical Inc — 1.82%
  6. Danaher Corp — 1.80%
  7. Stryker Corp — 1.62%
  8. Medtronic PLC — 1.59%
  9. McKesson Corp — 1.52%
  10. Elevance Health Inc — 1.19%
  11. Cigna Group/The — 1.06%
  12. Boston Scientific Corp — 1.00%
  13. HCA Healthcare Inc — 0.91%
  14. Cencora Inc — 0.83%

Only in FTXH

  1. Biogen Inc — 3.84%
  2. Viatris Inc — 3.62%
  3. United Therapeutics Corp — 2.72%
  4. Jazz Pharmaceuticals Plc — 2.49%
  5. Incyte Corp — 2.39%
  6. Illumina Inc — 1.98%
  7. Zoetis Inc — 1.87%
  8. Exelixis Inc — 1.72%
  9. Charles River Laboratories International Inc — 1.49%
  10. Medpace Holdings Inc — 1.41%
  11. Ptc Therapeutics Inc — 1.37%
  12. Neurocrine Biosciences Inc — 1.37%
  13. Alkermes Plc — 1.35%
  14. Halozyme Therapeutics Inc — 1.21%

Asset mix

Asset typeFHLCFTXH
Stocks99.7%99.9%
Cash & short-term funds0.2%0.1%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Country mix

CountryFHLCFTXH
US96.5%95.6%
IE2.2%3.8%
BM0.2%0.6%
GB0.5%—
CA0.2%—
CH0.1%—
NL0.1%—

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Check another pair

FAQ

How much do FHLC and FTXH overlap?
About 51% by weight. 11 securities appear in both funds' top 25 holdings; they make up 46.4% of FHLC's assets and 54.2% of FTXH's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do FHLC and FTXH have in common?
The largest shared holdings are Eli Lilly & Co, Johnson & Johnson, AbbVie Inc, Merck & Co Inc, Amgen Inc.
Should I own both FHLC and FTXH?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, FHLC or FTXH?
FHLC is broader, with 337 positions versus 51 for FTXH. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.